Reproductive Milestones as Predictors of Cardiometabolic Health: An Integrated Lifespan Perspective

Gynecologic health represents a dynamic interaction between endocrine regulation, metabolic homeostasis, inflammatory signaling, and cardiovascular adaptation across the female lifespan. Increasing evidence demonstrates that reproductive conditions such as polycystic ovary syndrome, endometriosis, uterine fibroids, hypertensive disorders of pregnancy, and menopause are not isolated clinical entities but manifestations of broader systemic processes. This review integrates high-impact clinical guidelines, consensus statements, and epidemiologic syntheses to construct a lifespan-based conceptual framework linking gynecologic milestones with long-term cardiometabolic risk. Polycystic ovary syndrome exemplifies the convergence of hyperandrogenism and insulin resistance with persistent vascular vulnerability. Endometriosis illustrates immune–endocrine interactions and chronic inflammatory pathways with potential systemic implications. Pregnancy-related hypertensive disorders function as prognostic markers of future cardiovascular disease, while the menopausal transition represents an endocrine inflection point that amplifies preexisting metabolic trajectories. The synthesis highlights inflammation as a unifying biological mediator and underscores the influence of global obesity and metabolic syndrome on reproductive outcomes. By reframing gynecology within systems medicine, this work emphasizes preventive reasoning, longitudinal risk stratification, and interdisciplinary care. A lifespan-integrated approach may strengthen medical education, improve early detection of cardiometabolic vulnerability, and redefine gynecologic practice as a cornerstone of long-term systemic health.